Final Exam: NURS5432 / NURS
5432 (Latest Update )
Family I (FNP 1) | Comprehensive
Questions with Answers | 100%
Correct | Grade A – UTA
Question:
What is PLLR?
Answer:
Pregnancy and Lactation Labeling Rule; FDA labeling system providing risk
summary, clinical considerations, and data for pregnancy, lactation, and
reproductive potential.
Question:
What are the three PLLR sections?
Answer:
8.1 Pregnancy, 8.2 Lactation, 8.3 Males and Females of Reproductive
Potential.
,Question:
During which stage is teratogenesis most likely to cause gross malformations?
Answer:
Embryonic period (Weeks 3-8).
Question:
What happens with teratogen exposure during fetal period (Week 9-
delivery)?
Answer:
Functional disruption rather than gross malformations.
Question:
Which influenza vaccine is recommended in pregnancy?
Answer:
Inactivated injectable influenza vaccine.
Question:
When is Tdap given during pregnancy?
Answer:
27-36 weeks gestation.
,Question:
Which vaccines are contraindicated in pregnancy?
Answer:
Live vaccines (MMR, Varicella, live influenza nasal spray, HPV, Zoster,
Smallpox).
Question:
Can Hepatitis B vaccine be given in pregnancy?
Answer:
Yes, if high risk.
Question:
Minimum folic acid recommendation in pregnancy?
Answer:
0.4 mg/day.
Question:
What are pregnancy risk factors?
Answer:
Extremes of maternal age, chronic disease (HTN, DM, renal disease), previous
preterm birth, infections, substance use, tobacco use.
, Question:
First-line nonpharmacologic treatment for constipation in pregnancy?
Answer:
High-fiber diet, increased fluids, exercise.
Question:
What is the dose of docusate sodium?
Answer:
50-100 mg PO daily.
Question:
What is the dose of docusate calcium?
Answer:
240 mg PO daily.
Question:
What is the dose of Senokot?
Answer:
1 tablet PO at bedtime.
5432 (Latest Update )
Family I (FNP 1) | Comprehensive
Questions with Answers | 100%
Correct | Grade A – UTA
Question:
What is PLLR?
Answer:
Pregnancy and Lactation Labeling Rule; FDA labeling system providing risk
summary, clinical considerations, and data for pregnancy, lactation, and
reproductive potential.
Question:
What are the three PLLR sections?
Answer:
8.1 Pregnancy, 8.2 Lactation, 8.3 Males and Females of Reproductive
Potential.
,Question:
During which stage is teratogenesis most likely to cause gross malformations?
Answer:
Embryonic period (Weeks 3-8).
Question:
What happens with teratogen exposure during fetal period (Week 9-
delivery)?
Answer:
Functional disruption rather than gross malformations.
Question:
Which influenza vaccine is recommended in pregnancy?
Answer:
Inactivated injectable influenza vaccine.
Question:
When is Tdap given during pregnancy?
Answer:
27-36 weeks gestation.
,Question:
Which vaccines are contraindicated in pregnancy?
Answer:
Live vaccines (MMR, Varicella, live influenza nasal spray, HPV, Zoster,
Smallpox).
Question:
Can Hepatitis B vaccine be given in pregnancy?
Answer:
Yes, if high risk.
Question:
Minimum folic acid recommendation in pregnancy?
Answer:
0.4 mg/day.
Question:
What are pregnancy risk factors?
Answer:
Extremes of maternal age, chronic disease (HTN, DM, renal disease), previous
preterm birth, infections, substance use, tobacco use.
, Question:
First-line nonpharmacologic treatment for constipation in pregnancy?
Answer:
High-fiber diet, increased fluids, exercise.
Question:
What is the dose of docusate sodium?
Answer:
50-100 mg PO daily.
Question:
What is the dose of docusate calcium?
Answer:
240 mg PO daily.
Question:
What is the dose of Senokot?
Answer:
1 tablet PO at bedtime.
